Cancer immunotherapy full speed ahead
Ann Oncol
.
2017 Dec 1;28(suppl_12):xii1-xii2.
doi: 10.1093/annonc/mdx739.
Authors
I Melero
1
2
3
,
B Navarro
4
5
6
,
A Teijeira
2
3
,
G Coukos
4
5
6
Affiliations
1
University of Navarra Clinic, Pamplona.
2
Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona.
3
CIBERONC, Madrid, Spain.
4
Ludwig Institute for Cancer Research, Lausanne.
5
Department of Oncology, University Hospital, Lausanne.
6
University of Lausanne, Lausanne, Switzerland.
PMID:
29253117
DOI:
10.1093/annonc/mdx739
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Humans
Immunotherapy / methods*
Neoplasms / immunology
Neoplasms / therapy*